- Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option?
-
Clément Desjardins, Christelle Nilles, David Devos, Emmanuel Roze
-
J Mov Disord. 2023;16(3):328-330. Published online June 9, 2023
-
DOI: https://doi.org/10.14802/jmd.23057
-
-
2,290
View
-
110
Download
-
2
Web of Science
-
2
Crossref
-
 PDF Supplementary Material
-
Citations
Citations to this article as recorded by  - Simultaneous activation of different subtypes of dopamine receptors may lead to activation of homeostatic sleep regulatory mechanisms
Dóra Keserű, Tünde Hajnik, Máté Pethő, László Détári, Maarten Van Den Bossche, Attila Tóth
Pharmacology Biochemistry and Behavior.2025; 248: 173954. CrossRef - Monotherapy with infusion therapies – useful or not?
Petra Bago Rožanković, Anders Johansson, Klivényi Péter, Ivan Milanov, Per Odin
Journal of Neural Transmission.2024; 131(11): 1341. CrossRef
|
KMDS
E-submission
